BIOMARIN ANNOUNCES U.S. LAUNCH OF ORAPRED ODT THROUGH ALLIANT PHARMACEUTICALS

BioMarin Pharmaceutical Inc. announced that Orapred ODT (prednisolone sodium phosphate orally disintegrating tablets), the first FDA-approved orally disintegrating tablet form of prednisolone, is now commercially available in the United States. The Orapred product line, which includes Orapred ODT and Orapred (prednisolone sodium phosphate oral solution) is marketed by Alliant Pharmaceuticals, Inc., pursuant to a North American license and acquisition agreement entered into on March 15, 2006.
PR Newswire